|
Back in December 2004, when we originally recommended specialty chemicals and paints group Imperial Chemical Industries (LSE, ICI), rising raw material inputs and a creaking balance sheet weighed on sentiment. However, we saw things differently. Restructuring programmes targeting millions in cost savings were a welcome step in bolstering margins. Combined with the ability to pass on higher costs to customers, we believed ICI was in a good position to buck market sentiment. This proved the case, with core turnover and earnings growing steadily.
Further restructuring ensued as non-core business units were disposed of. This process gained momentum as 2006 drew to a close with the sale of the 'Uniqema' and 'Quest' divisions for £1.6 billion.
We believed there was now a distinct possibility that a much nimbler ICI could become an acquisition target. After exiting part of the position in 2006 (on concerns that ICI itself could embark on the takeover trail) we maintained a holding for long term gains, given the real chance ICI might be the 'prey rather than the predator'.
And so it was. Rival Dutch coatings and specialty chemicals company, Akzo Nobel, tabled an initial offer at 600p per share in June. This was not sweet enough though, and Akzo returned with a cash offer of 670p.
Given the shakiness of some markets (the US particularly) we saw the plus side of accepting the deal and Members achieved an overall return of 195 percent on their remaining holdings. |